Boston Scientific (NYSE: BSX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 9.80%. A quarter ago, it was expected that this medical device manufacturer would post earnings of $0.51 per share when it actually produced earnings of $0.55, delivering a surprise of 7.84%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Boston Scientific, which belongs to the Zacks Medical - Products industry, posted revenues of $3.86 billion for the quarter ended March 2024, surpassing the Zacks Consensus Estimate by 4.85%. This compares to year-ago revenues of $3.39 billion. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Boston Scientific ...